PUBLIC COMPANY
save$SVRASavara Inc
$SVRA5.0800+0.20%Austin, TX, USupdated 1d ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
1
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1pre_registration
Upcoming
no upcoming catalysts on record
Recent(90d)
view all catalysts →Active trials
- phase3Inhaled Molgramostim in Pediatric Participants With Autoimmune Pulmonary Alveolar Proteinosis (aPAP).
- —Molgramostim Nebulizer Solution Expanded Access Program Protocol
- phase3Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
- phase3Safety Extension Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis
- phase2Pilot Trial of Inhaled Molgramostim in Non-tuberculous Mycobacterial (NTM) Infection
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 17m ago
Found something off?
comments(0)
5-min edit window · permanent after that